|
Volumn 7, Issue 6, 2001, Pages S8-
|
Pharmacologic and nonpharmacologic options for anxiety and depression in late life
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
ANALGESIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIINFECTIVE AGENT;
ANTIPARKINSON AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
CITALOPRAM;
CLONAZEPAM;
DIAZEPAM;
DOPAMINE UPTAKE INHIBITOR;
EFFEXOR SR;
FLUOXETINE;
FLUVOXAMINE;
LITHIUM;
MIRTAZAPINE;
MONOAMINE OXIDASE INHIBITOR;
NEFAZODONE;
NORADRENALIN UPTAKE INHIBITOR;
PAROXETINE;
PHENOTHIAZINE DERIVATIVE;
PSYCHOTROPIC AGENT;
SEROTONIN UPTAKE INHIBITOR;
STEROID;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VALPROIC ACID;
VENLAFAXINE;
ADULT;
AGING;
ANXIETY NEUROSIS;
ARTICLE;
AUTONOMIC DYSFUNCTION;
CARDIOVASCULAR DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL FEATURE;
CONFUSION;
CONTROLLED STUDY;
DEPRESSION;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG MECHANISM;
DRUG TOLERABILITY;
FUNCTIONAL DISEASE;
HIGH RISK POPULATION;
HUMAN;
LIFE EVENT;
MALE;
MEDICAL DECISION MAKING;
MENTAL DISEASE;
MENTAL HEALTH SERVICE;
NEUROTOXICITY;
PHYSICAL DISABILITY;
PSYCHOLOGIC ASSESSMENT;
|
EID: 0035670886
PISSN: 10783903
EISSN: None
Source Type: Journal
DOI: 10.1067/mpn.2001.120565 Document Type: Article |
Times cited : (2)
|
References (20)
|